GrowGeneration Joins U.S. Cannabis Roundtable, Eyes 280E Tax Relief Tailwind
GRWG•GrowGeneration has joined the U.S. Cannabis Roundtable, enhancing its federal policy advocacy role under CEO Darren Lampert’s representation. The recent shift of state-licensed medical cannabis toward Schedule III offers potential 280E tax relief, potentially boosting customer investments in cultivation infrastructure GrowGeneration supplies.
1. Membership Announcement
GrowGeneration announced it has become a member of the U.S. Cannabis Roundtable, with CEO Darren Lampert representing the company in federal policy discussions. USCR brings together leading operators and ancillary businesses from 41 states to advocate for standardized regulations and financial access.
2. Policy and Market Implications
The recent executive order shifting state-licensed medical cannabis toward Schedule III status introduces potential 280E tax relief for qualifying operators. This financial benefit is expected to increase customer investments in controlled environment agriculture infrastructure, directly supporting GrowGeneration’s product sales and service offerings.
